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Background: Aneurysm shrinkage has been proposed as a marker of successful endovascular
aneurysm repair (EVAR). Patients with early postoperative shrinkage may experience fewer subsequent
complications, and consequently require less intensive surveillance.
Methods: Patients undergoing EVAR from 2000 to 2011 at three vascular centres (in 2 countries),
who had two imaging examinations (postoperative and after 6–18 months), were included. Maximum
diameter, complications and secondary interventions during follow-up were registered. Patients were
categorized according to early sac dynamics. The primary endpoint was freedom from late complications.
Secondary endpoints were freedom from secondary intervention, postimplant rupture and direct (type
I/III) endoleaks.
Results: Some 597 EVARs (71·1 per cent of all EVARs) were included. No shrinkage was observed in
284 patients (47·6 per cent), moderate shrinkage (5–9 mm) in 142 (23·8 per cent) and major shrinkage (at
least 10 mm) in 171 patients (28·6 per cent). Four years after the index imaging, the rate of freedom from
complications was 84·3 (95 per cent confidence interval 78·7 to 89·8), 88·1 (80·6 to 95·5) and 94·4 (90·1 to
98·7) per cent respectively. No shrinkage was an independent risk factor for late complications compared
with major shrinkage (hazard ratio (HR) 3·11; P< 0·001). Moderate compared with major shrinkage (HR
2·10; P= 0·022), early postoperative complications (HR 3·34; P< 0·001) and increasing abdominal aortic
aneurysm baseline diameter (HR 1·02; P= 0·001) were also risk factors for late complications. Freedom
from secondary interventions and direct endoleaks was greater for patients with major sac shrinkage.
Conclusion: Early change in aneurysm sac diameter is a strong predictor of late complications after
EVAR. Patients with major sac shrinkage have a very low risk of complications for up to 5 years. This
parameter may be used to tailor postoperative surveillance.
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Introduction
Endovascular aneurysm repair (EVAR) is increasingly
being used as primary mode for abdominal aortic
aneurysm (AAA) repair in suitable patients owing to
reduced perioperative mortality compared with open
repair1. However, EVAR is associated with a significant
rate of complications over time2. Imaging surveillance
is considered mandatory to identify and treat these
complications before they result in life-threatening events
such as postimplant rupture or graft occlusion. In
many countries the burden of post-EVAR surveillance
is increasing rapidly.
Currently, there is no consensus on the frequency
of post-EVAR surveillance, method of imaging or
individual adaptation according to risk3–7. Computed
tomographic angiography (CTA), which is still regarded
as the standard for post-EVAR surveillance, is both
costly and associated with potential risks from radiation
and iodine contrast exposure, making strategies for
reduction of follow-up intensity of interest8,9. Patients
at low risk of late complications might require less
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intensive postoperative surveillance. Identification of
individual risk factors for stent failure may allow
surveillance to be tailored, focusing on patients at higher
risk and reducing the surveillance costs for those at
lower risk4,7,10,11.
Aneurysm sac shrinkage has been proposed as a marker
of successful endovascular aneurysm exclusion11–13. Con-
sequently, it could be expected that patients who have
significant shrinkage of the sac in the early postoper-
ative phase would experience fewer complications, and
consequently require less intensive imaging surveillance.
The aim of this study was to evaluate the role of early
AAA sac dynamics in determining long-term outcome
after EVAR.
Methods
This study involved three institutions with experi-
ence in EVAR, performing over 50 annual procedures
each. Two institutions are university hospitals (Upp-
sala University Hospital, Uppsala, Sweden, and Erasmus
University Medical Centre, Rotterdam, The Nether-
lands), and the third is a county hospital (Ga¨vle Hos-
pital, Ga¨vle, Sweden). The study complied with the
Helsinki declaration on research ethics, and local pro-
cedures for ethical clearance were followed at each
participating centre.
Patients
All patients treated with EVAR from January 2000 to
December 2011 at the three centres were assessed.
Patients with a history of aortic reconstructive surgery
or mycotic aneurysm were excluded. All three institutions
used a 55-mm maximum diameter threshold for AAA
intervention, and operated on smaller aneurysms only
in the event of symptoms or accelerated growth. The
inclusion criteria were: treatment of infrarenal aortoiliac
aneurysm; and availability of two consecutive postoperative
image examinations with the same technique (CTA or
duplex ultrasound imaging) 6–18months apart, with the
first scan performed within the first 30 days after surgery,
as recommended by the Society for Vascular Surgery
(SVS) reporting standards for EVAR14. Preoperative
examinations were used only when no early postoperative
imaging was available and if carried out within 60 days
before EVAR. The second of the two scans was considered
the index examination. The measurement collected was
the change in maximum aneurysm sac diameter between
the first and second examinations. Patients who had two
different imaging modalities during the first 18months
after EVAR were excluded from the assessment of
sac dynamics owing to variation between diameter
measurements between the tests.
Postoperative image surveillance protocols
Protocols for postoperative surveillance differed between
institutions, and also evolved over time. Typically,
however, CTA, duplex ultrasonography or both were per-
formed at regular intervals for all patients. All patients were
considered eligible independently of the protocol followed,
as evaluation of differences in surveillance strategy was not
the aim of this study. However, preference was given to
CTA-based measurements when CTA and duplex images
were available, to reduce observer variability and allow
post hoc confirmation of diameters. CTA measurements
were done using outer-to-outer diameters, and duplex
ultrasonography using leading-edge-to-leading-edge
measurements. Each institution used the same method-
ology for assessment of aneurysm diameter throughout
the study.
Data management
Data fromeach institutional databasewere anonymized and
entered into a study-specific database that recorded clinical
and anatomical baseline characteristics, and procedural
details including date, timing, intraoperative data, as
well as endograft model and configuration. All image
data were scrutinized by a single experienced vascular
surgeon at each centre and the following endpoints
were registered: diameter, and follow-up information
including all registered complications and secondary
interventions. All CTAs included a late arterial phase.
Maximum diameter was used for assessment of sac
dynamics as recommended in the SVS reporting standards
for EVAR14.
Definitions
Early sac shrinkage was defined as the difference in
maximum diameter between the first (within 30 days) and
the second (after 6–18months) scan. The second was
considered the index examination. Intraoperative compli-
cations were considered to have occurred if the device
was not deployed at the intended position, if type I
or III endoleak or graft obstruction was present, or if
unplanned endovascular or surgical procedures were nec-
essary. Clinical events (complications) were defined as any
of the following occurrences after the index examination:
direct (type I or III) or undetermined endoleak, endograft
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occlusion, postimplantation rupture, endograft infection,
migration exceeding 10mm or device integrity failure.
Undetermined endoleak was recorded if contrast was visu-
alized outside the endograft and within the aneurysm sac,
but the source could not be attributed to failure of a
proximal or distal seal or patent aortic branch vessels.
Persistent or late-onset type II endoleaks were consid-
ered separately, defined as type II endoleaks being present
beyond the first postoperative examination, or present-
ing after a previous endoleak-free examination. Secondary
interventions were those performed to resolve or pre-
vent a possible complication, and included endovascular
procedures (proximal cuff and stent implant, distal exten-
sion implant, catheter-based thrombolysis, iliac stenting,
coil or glue embolization of aortic branch vessels) as well
as surgical procedures (balloon thrombectomy, femoro-
femoral crossover, conversion to open repair, open or
laparoscopic ligation of collaterals). Early complications
were those that occurred before the second (index) exam-
ination, and late complications those that occurred after
this interval.
Shrinkage categories
Patients were divided into three groups, according to
the observed AAA sac dynamics at 1 year. A 5-mm
threshold was selected, as suggested by the SVS reporting
standards for diameter changes in the aneurysm sac14.
If the maximum aortic diameter increased, remained
stable or decreased by less than 5mm, patients were
included in the no shrinkage group. A reduction in AAA
diameter of between 5 and 9mm was categorized as
moderate shrinkage, and a reduction of 10mm or more as
major shrinkage.
Endpoints
The primary endpoint of this study was freedom
from any complication. Secondary endpoints were
freedom from reintervention, freedom from postimplan-
tation rupture, freedom from direct or undetermined
endoleaks, freedom from persistent or late-onset type
II endoleaks and freedom from endograft occlusion.
Only events occurring after the index imaging, which
was used to categorize patients, were considered in
this analysis.
Statistical analysis
Categorical variables were compared by means of χ2
linear-by-linear association tests. Continuous variables are
presented as mean(s.d.) if distributed normally and other-
wise as median (range or i.q.r.), with analysis using one-way
ANOVA for linearity. Estimates for the primary and sec-
ondary endpoints were obtained using the Kaplan–Meier
method and compared by means of the log rank test for
equality. A multivariable Cox regression model was created
to assess the independent influence of early sac dynamics
on late complication rates; variables included were: early
sac dynamics, baseline AAA diameter, rupture as surgical
indication, use of aortomonoiliac endoprosthesis, occur-
rence of intraoperative complications, and development
of complications before the index examination. Selection
bias was explored by comparing baseline characteristics,
overall survival, duration of follow-up, and complication
and secondary intervention rates in patients included or
excluded from the present study; in this analysis the latter
patients were those who survived the first 6months, and
were excluded only owing to lack of two consecutive
imaging examinations. Similarly, analysis of the primary
endpoint was also performed after excluding patients who
had surgery for ruptured AAA. To test the validity of cat-
egorization, the correlation between absolute and relative
diameter changes was tested using Spearman’s ρ, and com-
parison between absolute and proportional shrinkage was
performed for the primary endpoint. All tests were two-
sided, and P< 0·050 was considered significant. Statistical
analysis was done using SPSS version 20 (IBM, Armonk,
New York, USA).
Results
From 2000 to 2011, 840 patients were treated with EVAR
in the three participating institutions. Of these, 45 died
within 6months (27 operated on for ruptured AAA) and
198 were excluded as two equivalent consecutive scans
were not available within the specified interval, leaving 597
(71·1 per cent) for assessment of early AAA sac dynamics.
In 284 patients (47·6 per cent of the 597) no shrinkage was
observed. Among these, growth of 5mmormore was noted
in 14 (2·3 per cent). Moderate shrinkage (5–9mm) was
registered in 142 patients (23·8 per cent) and major shrink-
age (at least 10mm) in the remaining 171 (28·6 per cent).
The following endoprostheses were used in this cohort:
202 Excluder (W. L. Gore and Associates, Flagstaff,
Arizona, USA), 189 Endurant (Medtronic CardioVas-
cular, Santa Rosa, California, USA), 160 Zenith (Cook,
Bloomington, Indiana, USA), 25 Talent (Medtronic
CardioVascular) and 21 others. The median interval
between the first and second (index) examination was 360
(i.q.r. 264–397) days. Baseline characteristics are described
in Table 1.
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Table 1 Baseline characteristics of the three subgroups, based on early sac dynamics
No shrinkage Moderate shrinkage Major shrinkage
(n= 284) (n= 142) (n= 171) P¶
Age (years)* 74·2(7·2) 73·4(7·3) 72·1(7·6) 0·018#
Sex ratio (M : F) 243 : 41 114 : 28 149 : 22 0·462
Medical history
Ischaemic heart disease 121 of 274 (44·2) 56 of 137 (40·9) 69 of 162 (42·6) 0·757
Cerebrovascular disease 42 of 273 (15·4) 15 of 137 (10·9) 14 of 163 (8·6) 0·035
eGFR< 60‡ 47 of 184 (25·5) 20 of 86 (23) 36 of 129 (27·9) 0·525
Diabetes mellitus 44 of 274 (16·1) 17 of 137 (12·4) 21 of 163 (12·9) 0·355
Hypertension 175 of 274 (63·9) 86 of 136 (63·2) 107 of 163 (65·6) 0·676
Peripheral arterial disease 38 of 274 (13·9) 21 of 136 (15·4) 23 of 163 (14·1) 0·901
COPD 28 of 273 (10·3) 28 of 137 (20·4) 30 of 158 (19·0) 0·007
Maximum AAA diameter (mm)† 59 (36–110) 60 (32–110) 63 (35–139) < 0·001#
Operative details
Ruptured aneurysm 14 (4·9) 12 (8·5) 28 (16·4) < 0·001
Monoiliac stent configuration 11 (3·9) 7 (4·9) 6 (3·5) 0·939
Intraoperative complications 57 (20·1) 35 (24·6) 29 (17·0) 0·710
Proximal cuff/Palmaz 12 7 9
Iliac PTA/stenting 20 14 7
Iliac component extension 6 5 9
Other endovascular intervention 6 4 2
Other surgical intervention 4 5 1
Early postoperative complications§ 30 (10·6) 11 (7·7) 6 (3·5) 0·010
Index imaging
CTA measurements 251 (88·4) 106 (74·6) 148 (86·5) 0·445
Interval between two scans used for
assessment of sac dynamics (days)†
359 (173–541) 364 (170–549) 360 (170–549) 0·698#
Values in parentheses are percentages unless indicated otherwise; *values are mean(s.d.) and †median (range). ‡Estimated glomerular filtration rate
(eGFR) calculated using the Modification of Diet in Renal Disease formula: eGFR= 186× serum creatinine–1·154 × age –0·203 × [1·212 if black]× [0·742
if female]. §Before index imaging. COPD, chronic obstructive pulmonary disease; AAA, abdominal aortic aneurysm; PTA, percutaneous transluminal
angioplasty; CTA, computed tomographic angiography. Palmaz (Cordis, Bridgewater, New Jersey, USA). ¶χ2 test, except #one-way ANOVA.
Freedom from late complications, according
to aneurysm sac shrinkage
The total follow-up for the three groups was similar
(median 3·1–3·2 years) (Table 2). The follow-up of interest
for this study (after index image examination) was also
similar (median 2·2 years). A total of 58 patients (9·7 per
cent) developed complications during follow-up. These
were more frequent in the no shrinkage group than in
the moderate and major shrinkage groups (12·7, 9·9 and
4·7 per cent respectively; P = 0·038). Four years after the
index imaging, the rate of freedom from complications
was estimated at 84·3 (95 per cent confidence interval (c.i.)
78·7 to 89·8), 88·1 (80·6 to 95·5) and 94·4 (90·1 to 98·7)
per cent respectively (Fig. S1, supporting information).
Multivariable testing for potential risk factors for late
complications (occurring after the index examination)
revealed that, compared with major shrinkage, moderate
and no shrinkage increased the risk by 2·1 and 3·1
times respectively (Table 3). Other independent risk factors
for late complications were increasing preoperative AAA
diameter and a history of early postoperative complications
(Table 3). The use of discontinued endograft models did not
have independent prognostic influence.
Complications in the major shrinkage group
Eight patients (4·7 per cent) with early shrinkage of the
AAA sac of at least 10mm had late complications. Three
developed acute limb ischaemia owing to endograft limb
thrombosis, at 1, 11 and 16 months after the index imaging
(17, 18 and 26 months after EVAR). There were no
imaging changes suggesting an increased risk of these
events. Two patients had type I endoleaks: one type
Ia 6 months after the index scan (1·0 year after EVAR)
and one type Ib 2·7 years after the index scan (3·3 years
after EVAR). The patient with a type Ia endoleak had a
very short proximal seal zone (7mm) at the 30-day CTA,
despite a long proximal neck. The patient with a type Ib
endoleak had dilatation of an iliac artery that was already
wide (24mm) before surgery. One patient developed a
type III endoleak 12months after the index examination
(2 years after EVAR), owing to insufficient component
overlap at implantation. One patient had an aneurysm
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Table 2 Late outcome according to early aneurysm sac shrinkage
No shrinkage Moderate shrinkage Major shrinkage
(n= 284) (n= 142) (n= 171) P‡
Total follow-up (years)* 3·1 (0·5–11·9) 3·2 (0·5–12·2) 3·2 (0·5–12·7) 0·311§
Follow-up after index scan (years)* 2·2 (0–12·4) 2·2 (0–11·3) 2·2 (0–11·7) 0·277§
Complications 36 (12·7) 14 (9·9) 8 (4·7) 0·038
Patients who had secondary interventions 59 (20·8) 17 (12·0) 11 (6·4) < 0·001
Proximal extension cuff or stent 20 7 2
Limb component extensions 21 9 3
Coil/glue embolization 18 1 4
Open/laparoscopic collateral ligation 9 0 0
Conversion to open repair 9 2 3
Postimplantation rupture 3 (1·1) 1 (0·7) 1 (0·6) 0·819
Patients who had direct endoleak† 20 (7·0) 11 (7·7) 3 (1·8) 0·040
Type Ia 10 7 1 –
Type Ib 8 4 1 –
Type III 3 1 1 –
Undetermined type 2 1 0 –
Persistent or late-onset type II endoleak 55 (19·4) 9 (6·3) 9 (5·3) < 0·001¶
Endograft occlusion 5 (1·8) 3 (2·1) 3 (1·8) 0·979
Endograft infection 2 (0·7) 1 (0·7) 1 (0·6) 0·926
Values in parentheses are percentages unless indicated otherwise; *values are median (range). Only events after the index scan (at 6–18months) are
reported. †More than one endoleak may have occurred in the same patient. ‡Significance derived from univariable time-dependent statistical analysis
(Kaplan–Meier analysis and log rank test), except §one-way ANOVA and ¶χ2 test.
Table 3 Cox regression analysis of risk factors for late
complications
Hazard ratio P
Moderate shrinkage (versus major shrinkage) 2·10 (1·11, 3·98) 0·022
No shrinkage (versus major shrinkage) 3·11 (1·75, 5·53) < 0·001
AAA diameter (per mm increase) 1·02 (1·01, 1·04) 0·001
Treatment of intact (versus ruptured) AAA 0·87 (0·43, 1·79) 0·712
Aortomonoiliac stent design 2·00 (0·77, 5·23) 0·156
Intraoperative complications 1·32 (0·85, 2·04) 0·219
Complications before index examination 3·34 (2·21, 5·04) < 0·001
Values in parentheses are 95 per cent confidence intervals. AAA,
abdominal aortic aneurysm.
rupture 5·5 years after the index examination (6·5 years after
EVAR), without a previously visible endoleak, which was
treated successfully by urgent conversion to open repair.
Finally, one patient had endograft infection diagnosed
at the time of the index examination and died from
sepsis before graft excision. This patient had low-grade
fever before surgery, and was considered to have had an
inflammatory aneurysm; a mycotic primary aetiology was
suggested retrospectively.
Freedom from late secondary intervention, direct
endoleak, persistent or late-onset type II endoleak,
postimplant rupture and endograft occlusion
according to early sac shrinkage
Late secondary interventions after the index imaging were
needed in 87 patients overall (14·6 per cent). Patients with
no shrinkage had significantly more secondary interven-
tions than those with moderate and major shrinkage (20·8,
12·0 and 6·4 per cent respectively; P< 0·001) (Table 2). The
estimated rate of freedom from secondary intervention
4 years after the index imaging examination (5 years after
EVAR) was 76·6 (95 per cent c.i. 70·5 to 82·7), 81·8 (72·2
to 91·4) and 91·6 (85·9 to 97·3) per cent for no, moderate
and major shrinkage groups respectively (Fig. 1).
Late direct (or undetermined) endoleaks also occurred
less frequently in patients with major shrinkage, but no
significant difference was observed for patients with
moderate or no shrinkage. Estimates for rates of freedom
of direct or undetermined endoleaks 4 years after the index
imaging were 89·4 (95 per cent c.i. 84·1 to 94·6), 90·7 (83·8
to 97·6) and 97·2 (93·9 to 100) per cent for no,moderate and
major shrinkage groups respectively (Fig. S2, supporting
information).
Persistent or late-onset type II endoleaks were more
frequent in the no shrinkage group (19·4 per cent). No
difference was observed in the rate of persistent type II
endoleaks for the moderate and major shrinkage groups
(6·3 and 5·3 per cent respectively). Persistent or late-onset
type II endoleaks were associated with sac growth in 24
patients, of whom eight also had type I endoleaks. One
patient in each of themoderate andmajor shrinkage groups
had subsequent sac growth associated with a persistent,
isolated type II endoleak. No differences between groups
were observed in late postimplant rupture or endograft
occlusion (Table 2).
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Fig. 1 Kaplan–Meier plot for freedom from late secondary intervention, according to early sac shrinkage. P< 0·001 (log rank test)
Assessment of selection bias and sensitivity analysis
There were no differences in age and AAA diameter
between patients included in, or excluded from the study
(Table 4). Included patients had longer follow-up (median
3·2 versus 2·8months after EVAR; P< 0·001), but the
overall mortality rate did not differ significantly (26·1
versus 22·7 per cent; P = 0·396). However, similar numbers
of overall complications and secondary procedures were
observed in both groups.
In 18 patients (3·0 per cent) a preoperative exam-
ination was used to determine baseline diameter. No
differences were observed in median shrinkage (5 ver-
sus 4mm; P = 0·769) or group allocations (P = 0·226)
for patients with baseline diameters measured before or
after surgery.
Therewas a strong correlation between proportional and
absolute categorization of shrinkage (ρ= 0·988, P< 0·001).
Proportional categorization of groups (less than 10, 10–20
and more than 20 per cent shrinkage) would have resulted
in misclassification of shrinkage in 48·6 per cent of patients
with moderate shrinkage defined according to absolute
measurements (47·9 per cent misclassified as no shrinkage
and 0·7 per cent as major shrinkage) and misclassification
Table 4 Selection bias assessment
Included Excluded‡
(n= 597) (n= 198) P§
Total follow-up after EVAR
(years)*
3·2 (0·6–12·7) 2·8 (0·6–12·1) < 0·001¶
Age (years)† 73·4(7·4) 73·2(8·0) 0·658¶
Preoperative AAA diameter
(mm)†
63(14) 64(15) 0·303¶
Deaths 156 (26·1) 45 (22·7) 0·396
Total no. of secondary
complications
106 (17·7) 31 (15·7) 0·587
Total no. of secondary
interventions
109 (18·3) 32 (16·2) 0·591
Values in parentheses are percentages unless indicated otherwise; *values
are median (range) and †mean(s.d.). ‡Owing to image availability. §χ2
test, except ¶one-way ANOVA.
of major shrinkage in 33·3 per cent (32·2 per cent as
moderate shrinkage and 1·2 per cent as no shrinkage).
Importantly, concordance in the no shrinkage group was
98·9 per cent (Table 5). Crude complication rates among
patients with less than 10, 10–20 and over 20 per cent
shrinkage were 12·5, 7·8 and 2·9 per cent respectively
(P = 0·002). Four years after the index scan, the rate
of freedom from complications was estimated at 83·5,
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Table 5 Sensitivity analysis based on absolute versus proportional
categorization
Proportional categorization
of shrinkage (%)
Absolute shrinkage (mm) < 10 10–20 > 20
< 5 281 (98·9) 3 (1·1) 0 (0)
5–9 68 (47·9) 73 (51·4) 1 (0·7)
≥ 10 2 (1·2) 55 (32·2) 114 (66·7)
Values in parentheses are percentages.
93·1 and 96·5 per cent respectively (Fig. S3, supporting
information). In a multivariable model, less than 10 per
cent shrinkage was associated with an increased risk of
complications (HR 2·95, 95 per cent c.i. 1·48 to 6·16)
compared with more than 20 per cent shrinkage. Had
patients treated for ruptured AAA been excluded, the
proportion of patients with complications in each group
would not have differed (13·3 per cent for no shrinkage, 9·3
per cent for moderate shrinkage and 4·5 per cent for major
shrinkage). Similarly, the Cox regression model did not
change when patients with ruptured AAA were excluded
from the analysis.
If the definition of shrinkage extended beyond the first
year, 46 additional patients (7·7 per cent of all those eligible)
would have been classified as having either moderate or
major shrinkage. Intervention in one of these patients for
an isolated type II endoleak, despite absence of growth,
potentially interfered with the natural evolution of the
aneurysm sac. One patient was identified as having a
type Ib endoleak 6months after the index procedure,
with an uneventful subsequent follow-up. One patient was
identified as having proximal stent migration 5 years after
the index procedure, but there was no need for secondary
intervention because the proximal seal was sufficient. Two
patients had endograft limbocclusion during follow-up.No
other complications were noted for this group of patients.
Discussion
The present study confirms that early sac shrinkage is an
important prognostic factor for improved late outcome
after EVAR. Patients with major sac shrinkage during the
early postoperative phase have a low risk of subsequent
complications for up to 5 years. Conversely, patients in
whom early shrinkage does not occur are at higher risk of
complications and more often require secondary interven-
tions. These results may have important implications for
individualization of postoperative surveillance.
The importance of sac shrinkage has been investigated
previously, and contraction of the aneurysm sac has been
suggested as a marker for success after EVAR. In a
recent publication involving 1450 procedures, Cieri and
colleagues15 reported that persistent shrinkage of the AAA
sac (over 5mm) was associated with rates of freedom
from AAA-related death at 3 and 10 years of 100 and
99·7 per cent respectively. Houbballah and co-workers11
reported no postimplant ruptures or conversions, and very
low rates of type I leak (2·2 per cent) and secondary
intervention (3·3 per cent) at a mean follow-up of 4·2 years,
for patients with significant sac contraction. Both authors
concluded that significant contraction of the aneurysm
sac is a robust predictor of success, which is in line
with the present findings. However, these studies did not
specifically investigate aneurysm sac shrinkage in the early
postoperative phase, which limits the potential to apply
their findings to individualized surveillance algorithms
defined at an early stage.
Lee et al.12 showed that a volume reduction of greater
than 10 per cent 6months after EVAR was a strong
predictor of clinical success. The present study confirms
this in a larger, contemporary series, adding that different
degrees of shrinkage have different prognostic impact.
Although measuring volume improved the accuracy of sac
dynamics16, the added value is still undetermined and it is
impractical in a clinical setting, compared with diameter
measurement.
The observed differences in type and number of
postoperative complications according to sac shrinkage
could potentially be related to the preoperative aneurysm
anatomy and the sealing length achieved at time of stent
implantation. The importance of adequate seal length as
verified on early postoperative imaging was confirmed
previously as a strong prognostic factor for late EVAR
outcome10. In the present study, early postoperative
complications were more common in the no shrinkage
group. Lack of early complications may be interpreted as
a surrogate for adequate implantation, which is in line
with previous research. For the present study, however,
this hypothesis could not be tested, as detailed baseline
anatomical variables and postoperative seal length were
not available for all patients.
Using sac shrinkage as a marker for success may not
be applicable to limb occlusion complications. Late limb
occlusion occurred uniformly in approximately 2 per
cent of patients of all groups (Table 2), suggesting that
shrinkage did not affect the risk of this complication
in the long term. Most early limb occlusions are
detectable on imaging and the result of a technical
flaw, whereas late occlusions occur mostly without prior
image findings17.
The present results have implications for post-EVAR
surveillance. After 1 year, patients may be stratified on
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the basis of sac shrinkage, and postoperative surveillance
may be tailored to the expected risk of complications.
Here, only 4·7 per cent of the patients with at least
10mm sac shrinkage at 1 year had late complications, of
which only three of eight were potentially preventable or
predictablewith surveillance imaging (2 type I and 1 type III
endoleaks). Early postoperative characteristics could have
predicted an increased risk of late complications in these
three patients (very short seal or insufficient component
overlap). Patients withmajor shrinkage of the aneurysm sac
may benefit from adapted surveillance towards symptom-
based investigations only, avoiding the need for routine
investigations4,8,9.
This study has several limitations, restricting firm con-
clusions. First, it is a retrospective study and may be
subject to selection bias; compliance with institutional
surveillance protocols is unknown. Furthermore, thresh-
olds for interventionmay have differed between institutions
and over time. On the other hand, the results are based
on a large international sample derived from prospec-
tively collected data from three different hospitals, using
a real-world variety of different endoprostheses. Another
limitation is that the population is essentially northern
European, and the results may not be generalizable to
all ethnic groups. Patient categorization was based on an
absolute (not proportional) reduction in diameter. As a
result, patients with a smaller preoperative AAA were less
likely to show sac shrinkage at 1 year, and similarly patients
with ruptured AAAs were more likely to be included in
the major shrinkage group (as their preoperative maximum
AAA diameter was generally greater). The use of absolute
reduction in sac diameter for definition of groups could
potentially have resulted in misclassification of smaller
or very large AAAs. The sensitivity analysis showed that
classification of patients based on proportional diameter
decrease would have yielded similar results. Interesting
differences at baseline between groups suggest a possible
prognostic influence of age, chronic obstructive pulmonary
disease, maximum AAA diameter and type of presentation
(intact versus ruptured AAA). Detailed anatomical base-
line characteristics with known prognostic impact (such
as iliac diameter or tortuosity) were not available for
all patients and could not be integrated into the multi-
variable model. Furthermore, as not all patients had
the necessary imaging for inclusion, a chance of selec-
tion bias remains. The authors assessed the risk of bias
by analysing the baseline characteristics and complica-
tion rates of patients excluded or included and found no
differences, although the duration of follow-up differed
slightly. Finally, the temporal restriction on categorization
of patients may have resulted in misclassification. In the
sensitivity analysis, it was found that a further 7·7 per cent
of patients could have been classified as having major sac
shrinkage if the difference between scans had been extended
beyond 1 year; these patients developed few complica-
tions over the course of follow-up. However, the authors
opted to restrict the classification interval to allow early
stratification.
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